Progressive Longevity LLC is categorized under Family Practice Doctors in Pompano Beach, FL and active since 2004.
Progressive Longevity LLC was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Chris Capece at the company’s single location by writing to 8217 West Atlantic Boulevard, Pompano Beach, Florida FL 33071 or by phoning (954) 757-1211. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Progressive Longevity LLC |
| Contact Person: | Chris Capece |
| Address: | 8217 West Atlantic Boulevard, Pompano Beach, Florida 33071 |
| Phone Number: | (954) 757-1211 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Progressive Longevity LLC was started in 2004 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Chris Capece for inquiries that concern Progressive Longevity LLC by calling the company number (954) 757-1211, as your correspondence is most welcome. Additionally, the physical location of the single location of Progressive Longevity LLC can be found at the coordinates as well as the street address 8217 West Atlantic Boulevard in Pompano Beach, Florida 33071.
For its online presence, you may visit Progressive Longevity LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.